Category: Zacks Small Cap Research

12345613640 / 1353 POSTS
By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT Second Quarter 2021 Financial and Operational Results On August 16, 2021, Reviva Pharmaceutical Holdings, Inc. (NASDAQ: RVPH) presented to investors its second quarter 2021 fi ...
By John Vandermosten, CFA NYSE:CVM READ THE FULL CVM RESEARCH REPORT Third Quarter Fiscal Year 2021 Operational and Financial Results CEL-SCI Corporation (NYSE: CVM) announced third quarter fiscal year 2021 results, filing Form 10-Q with the SEC on ...
By M. Marin OTC:NVNXF READ THE FULL NVNXF RESEARCH REPORT Positive implications strategic investment • Important relationship with major industry player • Facilitates and helps fund production expansion • Facilitates access to critical precursor m ...
By Lisa Thompson OTC:POETF | TSX:PTK.V READ THE FULL POETF RESEARCH REPORT POET (OTC:POETF) (TSX:PTK.V) has been trying to show customers the radical improvements its platform can offer them and will be providing demos with its partner Siluxtek at it ...
By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Business Update Update on Phase 1 Trial of EPI-7386 ESSA Pharma Inc. (NASDAQ:EPIX) is currently conducting a Phase 1 clinical trial of EPI-7386 in patients with metastatic castration- ...
By Steven Ralston, CFA OTCQX:ALVOF | TSX:ALV.V READ THE FULL ALVOF RESEARCH REPORT Alvopetro Energy Ltd (OTCQX:ALVOF) (TSX:ALV.V) is an upstream natural gas producer (natural gas production with P-2 reserves) and midstream operator (pipeline and ...
By TIm Moore, CFA NASDAQ:YTRA READ THE FULL YTRA RESEARCH REPORT First Quarter Financial & Operational Results On August 19, 2021, Yatra Online, Inc. (NASDAQ:YTRA) announced its first fiscal quarter financial and operational results. June Quarter ...
By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update COVID-19 Pipeline Update Tonix Pharmaceutical Holdings Corp. (NASDAQ:TNXP) has multiple programs targeting the current COVID-19 pandemic and is expanding its R&D a ...
By David Bautz, PhD NASDAQ:DFFN READ THE FULL DFFN RESEARCH REPORT Business Update Preparing for Two Additional Oxygenation Trials in 4Q21 Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) is in the process of evaluating its lead development compound, tr ...
By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Positive Preclinical Data for Filovirus Vaccine Candidates On August 18, 2021, Soligenix, Inc. (NASDAQ:SNGX) announced positive preclinical data for three filovirus va ...
12345613640 / 1353 POSTS